LBS 2 specifically detects human urothelium cell lines, tending to recognise the least anaplastic types.
| Inventor | Institute |
|---|---|
| Jenny Southgate ; Ludwik Trejdosiewicz | Cancer Research UK, London Research Institute: Lincoln's Inn Fields |
| SKU: | 151736 |
|---|---|
| Product description: | The urothelium is the lining of the ureters, bladder, and urethra. LBS 2 specifically detects human urothelium cell lines, tending to recognise the least anaplastic types. |
| Conjugation: | Unconjugated |
| Isotype: | IgM |
| Immunogen: | Human urothelial carcinoma -derived RT112 cells. |
| Myeloma used: | Sp2/0-Ag14 |
| Cat. #: | 151736 |
|---|---|
| Provenance and Ownership: | The Anti-Urothelium [LBS2] is owned by Cancer Research UK. CancerTools supplies the Anti-Urothelium [LBS2] under licence from Cancer Research UK and is the authorised source for its distribution. Sourcing Anti-Urothelium [LBS2] directly from the IP owner ensures authenticity, provenance and compliance with all applicable licensing and research use requirements. |
| Tool sub type: | Primary antibody |
| Unit size: | 100 ug |
| Research Fields: | Cell biology |
| Application: | IHC |
| Target: | Urothelium |
| Reactivity: | Human ; Mouse |
| Clone: | LBS2 |
| Host: | Mouse |
| Class: | Monoclonal |
| Target background: | The urothelium is the lining of the ureters, bladder, and urethra. LBS 2 specifically detects human urothelium cell lines, tending to recognise the least anaplastic types. |
|---|
| Format: | Liquid |
|---|---|
| Concentration: | 0.9-1.1 mg/ml |
| Storage buffer: | PBS with 0.02% azide |
| Storage conditions: | -15° C to -25° C |
| Shipping conditions: | Dry ice |
| References: |
Matthews et al. 1985. Biochem Soc Trans. 13:122-3 Trejdosiewicz et al. 1985. J Urol. 133(3):533-8. PMID: 2579255. Monoclonal antibodies to human urothelial cell lines and hybrids: production and characterization. |
|---|
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.